Challenges in interpreting comprehensive biomarker testing and a few paths to address them

Liquid biopsies and cancer: The role of NGS, CTC, exosomes, cfDNA and cfRNA

Predictive and prognostic biomarkers for immunotherapy in lung cancer

Molecular oncology and translational medicine

Adjuvant nivolumab vs placebo in resected oesophageal or gastroesophageal junction cancer following chemo: Biomarker analysis

Lenvatinib plus pembrolizumab versus standard of care for previously treated metastatic colorectal cancer

FOLFOX with selective use of 5FUCRT is non-inferior to 5FUCRT for treatment of LARC prior to low anterior resection with TME

Efficacy and safety of belantamab mafodotin vs pomalidomide plus dexamethasone in relapsed/refractory multiple myeloma

Triplets for newly diagnosed unfit AML patients could be feasible with substantial venetoclax reduction

ASCO 2023: Highlights and analysis

Axi-cel improves survival in early r/r large B-cell lymphoma

HCC: Improvement in RFS for atezolizumab plus bevacizumab vs active surveillance without compromising QoL